Heart LVADS

10.5% CAGR from 2018-2024

2017                                 2024
$1.024 billion                 $2.043 billion

Market growth from

Heart failure increases

Lack of suitable organ donors

Growing device/therapy approvals

Technological product design advancements

Comparison

Pulsatile-flow

Internal chamber, inflow/outflow valves, pneumatic or electric driven

Large diameter percutaneous leads

Loud functioning sound

High friction in pump

High morbidity (hemolysis)

Continuous-flow

Non-pulsatile flow: no valves, small cannulas, magnetically coupled motor (direct-drive, self-bearing, or bearing-less), or axial rotor

Quieter, better durability (simpler mechanics)

Increased blood flow (10L/min) reduced blood stasis and hemolysis

Component functions

Inflow cannula: Drains blood from left ventricle/left atrium

Mechanical impella (pump): Propels blood

Outflow cannula: Returns blood to aorta

Drive line: Connects to external portable driver, power supply

Uses

Destination therapy

Bridge-to-transplantation

Bridge-to-recovery

Globally

Largest share of market – Bridge-to-transplant

Fastest growing segment – Destination therapy

Major market share – North America

Fastest growth rate – Asia-Pacificp

Key players

Abbot Laboratories

Abiomed

Berlin Heart

Thoratec

Jarvik Heart

Heart Ware

Apaxis

CorWave

Evaheart

Reliantheart

MAIN Image: courtesy of St. Jude Medical Inc / INSET: Courtesy of ReliantHeart.com